Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial

Mariusz Tomaniak; P Chichareon; K Takahashi; N Kogame; R Modolo; Chun-Chin Chang; Ernest Spitzer; FJ Neumann; S Plante; RH Antolin; Z Jambrik; V Gelev; P Brunel; M Konteva; F Beygui; JF Morelle; KJ Filipiak; Robert Jan van Geuns; Osama Soliman; J Tijssen; T Rademaker-Havinga; RF Storey; C Hamm; PG Steg; S Windecker; Yoshinobu Onuma; M (Marco) Valgimigli; PWJC (Patrick) Serruys

doi:10.1093/ehjcvp/pvz052

Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial

Mariusz Tomaniak, P Chichareon, K Takahashi, N Kogame, R Modolo, Chun-Chin Chang, Ernest Spitzer, FJ Neumann, S Plante, RH Antolin, Z Jambrik, V Gelev, P Brunel, M Konteva, F Beygui, JF Morelle, KJ Filipiak, Robert Jan van Geuns, Osama Soliman, J TijssenT Rademaker-Havinga, RF Storey, C Hamm, PG Steg, S Windecker, Yoshinobu Onuma, M (Marco) Valgimigli, PWJC (Patrick) Serruys

Cardiology

Research output: Contribution to journal › Article › Academic › peer-review

11 Citations (Scopus)

30 Downloads (Pure)

Original language	English
Pages (from-to)	222-230
Number of pages	9
Journal	European Heart Journal. Cardiovascular pharmacotherapy
Volume	6
Issue number	4
DOIs	https://doi.org/10.1093/ehjcvp/pvz052
Publication status	Published - 2020

Research programs

EMC COEUR-09

Access to Document

10.1093/ehjcvp/pvz052

Repub_129112.pdfFinal published version, 677 KB

http://hdl.handle.net/1765/129112

Cite this

Tomaniak, M., Chichareon, P., Takahashi, K., Kogame, N., Modolo, R., Chang, C.-C., Spitzer, E., Neumann, FJ., Plante, S., Antolin, RH., Jambrik, Z., Gelev, V., Brunel, P., Konteva, M., Beygui, F., Morelle, JF., Filipiak, KJ., van Geuns, R. J., Soliman, O., ... Serruys, PWJC. (2020). Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial. European Heart Journal. Cardiovascular pharmacotherapy, 6(4), 222-230. https://doi.org/10.1093/ehjcvp/pvz052

@article{302dbbdbb85b480c91b937a98c4ab2d8,

title = "Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial",

author = "Mariusz Tomaniak and P Chichareon and K Takahashi and N Kogame and R Modolo and Chun-Chin Chang and Ernest Spitzer and FJ Neumann and S Plante and RH Antolin and Z Jambrik and V Gelev and P Brunel and M Konteva and F Beygui and JF Morelle and KJ Filipiak and \{van Geuns\}, \{Robert Jan\} and Osama Soliman and J Tijssen and T Rademaker-Havinga and RF Storey and C Hamm and PG Steg and S Windecker and Yoshinobu Onuma and Valgimigli, \{M (Marco)\} and Serruys, \{PWJC (Patrick)\}",

year = "2020",

doi = "10.1093/ehjcvp/pvz052",

language = "English",

volume = "6",

pages = "222--230",

journal = "European Heart Journal. Cardiovascular pharmacotherapy",

issn = "2055-6837",

publisher = "Oxford University Press",

number = "4",

}

Tomaniak, M, Chichareon, P, Takahashi, K, Kogame, N, Modolo, R, Chang, C-C, Spitzer, E, Neumann, FJ, Plante, S, Antolin, RH, Jambrik, Z, Gelev, V, Brunel, P, Konteva, M, Beygui, F, Morelle, JF, Filipiak, KJ, van Geuns, RJ, Soliman, O, Tijssen, J, Rademaker-Havinga, T, Storey, RF, Hamm, C, Steg, PG, Windecker, S, Onuma, Y, Valgimigli, M & Serruys, PWJC 2020, 'Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial', European Heart Journal. Cardiovascular pharmacotherapy, vol. 6, no. 4, pp. 222-230. https://doi.org/10.1093/ehjcvp/pvz052

Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial. / Tomaniak, Mariusz; Chichareon, P; Takahashi, K et al.
In: European Heart Journal. Cardiovascular pharmacotherapy, Vol. 6, No. 4, 2020, p. 222-230.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial

AU - Tomaniak, Mariusz

AU - Chichareon, P

AU - Takahashi, K

AU - Kogame, N

AU - Modolo, R

AU - Chang, Chun-Chin

AU - Spitzer, Ernest

AU - Neumann, FJ

AU - Plante, S

AU - Antolin, RH

AU - Jambrik, Z

AU - Gelev, V

AU - Brunel, P

AU - Konteva, M

AU - Beygui, F

AU - Morelle, JF

AU - Filipiak, KJ

AU - van Geuns, Robert Jan

AU - Soliman, Osama

AU - Tijssen, J

AU - Rademaker-Havinga, T

AU - Storey, RF

AU - Hamm, C

AU - Steg, PG

AU - Windecker, S

AU - Onuma, Yoshinobu

AU - Valgimigli, M (Marco)

AU - Serruys, PWJC (Patrick)

PY - 2020

Y1 - 2020

U2 - 10.1093/ehjcvp/pvz052

DO - 10.1093/ehjcvp/pvz052

M3 - Article

C2 - 31876907

SN - 2055-6837

VL - 6

SP - 222

EP - 230

JO - European Heart Journal. Cardiovascular pharmacotherapy

JF - European Heart Journal. Cardiovascular pharmacotherapy

IS - 4

ER -

Tomaniak M, Chichareon P, Takahashi K, Kogame N, Modolo R, Chang CC et al. Impact of chronic obstructive pulmonary disease and dyspnoea on clinical outcomes in ticagrelor treated patients undergoing percutaneous coronary intervention in the randomized GLOBAL LEADERS trial. European Heart Journal. Cardiovascular pharmacotherapy. 2020;6(4):222-230. doi: 10.1093/ehjcvp/pvz052